• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis.

作者信息

Hamano Takayuki, Fukagawa Masafumi

机构信息

Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Nephrology, The University of Osaka Graduate School of Medicine, Osaka, Japan.

Department of Medicine, Ikegami General Hospital, Tokyo, Japan; Division of Nephrology and Kidney Center, Kobe University School of Medicine, Kobe, Japan; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.

出版信息

Kidney Int. 2024 Aug;106(2):191-195. doi: 10.1016/j.kint.2024.06.003.

DOI:10.1016/j.kint.2024.06.003
PMID:39032965
Abstract
摘要

相似文献

1
Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis.EPISODE试验的结果呼吁对透析患者采取基于合理实践的血清磷酸盐降低措施。
Kidney Int. 2024 Aug;106(2):191-195. doi: 10.1016/j.kint.2024.06.003.
2
Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.终末期肾病中的磷平衡：针对低显性隐匿池的饮食、透析和磷结合剂。
J Nephrol. 2015 Aug;28(4):415-29. doi: 10.1007/s40620-014-0142-4. Epub 2014 Sep 23.
3
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.终末期肾病试验中的两个磷酸盐靶点（TARGET）：一项随机对照试验。
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):965-973. doi: 10.2215/CJN.10941016. Epub 2017 May 26.
4
Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken.基于关联而非因果关系来使血清磷酸盐正常化？透析领域的经验本应教会我们不要去修复我们无法证明已损坏的东西。
Kidney Int. 2024 Aug;106(2):195-199. doi: 10.1016/j.kint.2024.05.020.
5
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.一项针对血液透析患者不同血清磷范围的随机对照试验。
BMC Nephrol. 2019 Feb 4;20(1):37. doi: 10.1186/s12882-019-1216-2.
6
[Hyperphosphatemia in dialysis: which binder?].[透析中的高磷血症：哪种磷结合剂？]
G Ital Nefrol. 2018 Sep;35(5).
7
Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders.透析患者的高磷血症：不仅仅是不遵守饮食和结合剂的规定。
Am J Kidney Dis. 2016 Feb;67(2):182-6. doi: 10.1053/j.ajkd.2015.07.035. Epub 2015 Oct 23.
8
Phosphate Binders and Targets Over Decades: Do We have it Right Now?数十年来的磷酸盐结合剂与治疗靶点：我们目前是否正确？
Semin Dial. 2017 Mar;30(2):134-141. doi: 10.1111/sdi.12568. Epub 2017 Jan 8.
9
Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis.终末期肾病高磷血症患者使用替纳普仑的疗效和安全性：系统评价和荟萃分析。
Ren Fail. 2024 Dec;46(2):2410389. doi: 10.1080/0886022X.2024.2410389. Epub 2024 Oct 1.
10
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.HiLo 研究的设计与原理：维持性血液透析患者磷管理的实用随机临床试验。
Am J Kidney Dis. 2021 Jun;77(6):920-930.e1. doi: 10.1053/j.ajkd.2020.10.008. Epub 2020 Dec 3.